Publication | Closed Access

Therapeutic effects of TAK-242, a novel selective Toll-like receptor 4 signal transduction inhibitor, in mouse endotoxin shock model

InflammationToll-like ReceptorsCytokineSignal TransductionMedicineInnate Immune SystemImmunologySignal Transduction InhibitorCell DeathTherapeutic EffectsAutoimmunityImmunopathologyPharmacologyCell Signaling